Apple may finally introduce blood glucose monitoring to its Apple Watch lineup within the next two years, according to a newly revealed product roadmap from GF Securities analyst Jeff Pu. This advancement could mark a major leap in wearable health tech, especially for those managing diabetes or closely monitoring their health.
Despite Apple’s ambitious goals, progress has been slow due to technical challenges and form factor constraints. 
A key hurdle has been the size of the glucose sensor, which previously made integration into the compact design of the Apple Watch impractical. However, as of 2023, the non-invasive sensor reportedly reached a ‘proof of concept’ stage, suggesting Apple is making significant strides.
The product roadmap, shared by leaker @Jukanlosreve and reported by AppleInsider, aligns with Apple’s broader plans for expanding its health-focused wearables. In addition to glucose monitoring, Pu also predicts the arrival of the more budget-friendly Apple Vision Air and a set of smart glasses in 2027, pointing to a busy few years ahead for the tech giant.
Still, not all details are clear. It remains unknown whether the premium Apple Watch Ultra will include the blood glucose feature or if it will remain exclusive to the standard models. Also, the hardware seen in a recent prototype remains unverified, and Apple has yet to confirm any plans through official channels or supply chain leaks.
As with all speculative reports, this information should be taken cautiously. While Pu has a solid track record, Apple’s product development can be unpredictable. That said, if the prediction holds, Apple Watch users may soon gain access to a groundbreaking health tool-without the need for finger pricks.